In the April–June 2014 edition of Corporate Disputes, Group Vice President and Global Practice Leader Dr. Gregory Bell and other industry experts discuss pharma and biotech patent litigation.
An economic analysis of the artificial intelligence-copyright nexus
Among the large number of policy issues that are raised by the introduction and expanded use of Artificial Intelligence (“AI”) – its potential for the creation...